On April 10, 2024, the Centers for Medicare and Medicaid Services (CMS) released their proposed Inpatient Hospital payment rule for FY 2025. The proposed changes are a mixed bag for the nation’s inpatient hospitals and some of the provisions will need to be monitored before the rule is finalized.
On April 9, 2024, the Senate Finance Health Subcommittee held a roundtable discussion entitled, “Closing Gaps in the Care Continuum: Opportunities to Improve Substance Use Disorder Care in the Federal Health Programs.” The meeting touched on several topics within the subject of SUD care including access to medication assisted treatment, Medicare and Medicaid reimbursement of SUD care, and the need for evidence-based care.
On April 30, 2024, the House Energy and Commerce Health Subcommittee held a hearing entitled “Legislative Proposals to Increase Medicaid Access and Improve Program Integrity.” This hearing featured a discussion of several bills related to the Medicaid program.
On March 21, 2024, the House Energy and Commerce Health Subcommittee held a hearing on Food and Drug Administration (FDA) regulation of laboratory developed tests (LDTs) and the impact of FDA’s proposed rule on patient access.
On March 20, 2024, the House Energy and Commerce Health Subcommittee held a markup of 19 health care bills. These bills included legislation to create, reauthorize, or make changes to several programs designed to improve understanding and care of various diseases and conditions.
